{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T03:16:38Z","timestamp":1771038998584,"version":"3.50.1"},"reference-count":59,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T00:00:00Z","timestamp":1659571200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Selective serotonin reuptake inhibitors (SSRI) are the most common antidepressants used by pregnant women. However, adverse pregnancy outcomes have been described in women taking SSRI during pregnancy\u2014placental lesions, premature birth, poor neonatal adaptation. We aimed to investigate the effects of fluoxetine (Prozac<jats:sup>\u00ae<\/jats:sup> most commonly used SSRI) treatment during the last month of gestation on pregnancy complications, placental and neonatal health in a non-depressed sheep model. On day 119 \u00b1 1 postbreeding (experimental day 0; E0) of a 151-day expected gestation, Hampshire ewes were randomly assigned to receive fluoxetine (<jats:italic>n<\/jats:italic> = 9 ewes, 15 lambs; daily intravenously treatment with 10 mg\/kg on E0 and E1 and 5 mg\/kg daily thereafter until parturition) or to a control group (<jats:italic>n<\/jats:italic> = 10; 14 lambs; vehicle only). Blood samples from ewes were collected throughout the experimental period and postpartum; blood from lambs were collected postpartum. Analysis of variance was used for statistical analysis. Fluoxetine treatment reduced placentome growth during the last month of pregnancy. Gestation length was decreased by 4.5 days in fluoxetine-treated ewes. Birthweight was reduced in lambs exposed to fluoxetine <jats:italic>in utero<\/jats:italic>; weights remained decreased until postnatal day 3. Placentome diameter by birthweight ratio was not different between groups suggesting that the decreased placentome diameter was accompanied by decreased lamb birthweight. During the first week postnatal, lambs exposed to fluoxetine <jats:italic>in utero<\/jats:italic> had decreased blood pH and decreased total carbon dioxide, bicarbonate, and base excess and increased lactate (days 3\u20136), collectively indicative of metabolic acidemia. Additionally, ionized calcium was decreased between postnatal days 0 to 4 in lambs exposed to fluoxetine <jats:italic>in utero<\/jats:italic>. Using a non-depressed animal model clearly defines a role for SSRI on the occurrence of perinatal complications and neonatal morbidity. The decreased placentome diameter, shortened gestation, decreased birthweight, decreased calcium levels, and neonatal acidemia suggest the occurrence of intrauterine growth restriction. The persistence of neonatal acidemia for several days postpartum suggests poor neonatal adaptation to extrauterine environment.<\/jats:p>","DOI":"10.3389\/fmed.2022.955560","type":"journal-article","created":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T04:45:57Z","timestamp":1659588357000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Fluoxetine-induced perinatal morbidity in a sheep model"],"prefix":"10.3389","volume":"9","author":[{"given":"Rafael R.","family":"Domingues","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam D.","family":"Beard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meghan K.","family":"Connelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milo C.","family":"Wiltbank","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura L.","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/698947","article-title":"Selective serotonin reuptake inhibitors in human pregnancy: to treat or not to treat?","volume":"2012","author":"Diav-Citrin","year":"2012","journal-title":"Obstet Gynecol Int."},{"key":"B2","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1001\/archpsyc.63.8.898","article-title":"Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data","volume":"63","author":"Oberlander","year":"2006","journal-title":"Arch Gen Psychiatry."},{"key":"B3","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1053\/j.semperi.2015.08.010","article-title":"SSRI use during pregnancy","volume":"39","author":"Tran","year":"2015","journal-title":"Semin Perinatol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fncel.2013.00047","article-title":"Placental serotonin: implications for the developmental effects of SSRIs and maternal depression","volume":"7","author":"Velasquez","year":"2013","journal-title":"Front Cell Neurosci."},{"key":"B5","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s40263-016-0338-3","article-title":"Safety of selective serotonin reuptake inhibitors in pregnancy: a review of current evidence","volume":"30","author":"Alwan","year":"2016","journal-title":"CNS Drugs."},{"key":"B6","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.jad.2018.08.061","article-title":"A meta-analysis of selective serotonin reuptake inhibitors (SSRIs) use during prenatal depression and risk of low birth weight and small for gestational age","volume":"241","author":"Zhao","year":"2018","journal-title":"J Affect Disord."},{"key":"B7","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/j.1365-2885.2008.00944.x","article-title":"Serotonin: a review","volume":"31","author":"Mohammad-Zadeh","year":"2008","journal-title":"J Vet Pharmacol Ther."},{"key":"B8","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1097\/00004714-200204000-00005","article-title":"Serotonin and fluoxetine levels in plasma and platelets after fluoxetine treatment in depressive patients","volume":"22","author":"Blardi","year":"2002","journal-title":"J Clin Psychopharmacol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.biochi.2018.12.016","article-title":"The relationship between the placental serotonin pathway and fetal growth restriction","volume":"161","author":"Ranzil","year":"2019","journal-title":"Biochimie."},{"key":"B10","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.placenta.2019.05.012","article-title":"Disrupted placental serotonin synthetic pathway and increased placental serotonin: Potential implications in the pathogenesis of human fetal growth restriction","volume":"84","author":"Ranzil","year":"2019","journal-title":"Placenta."},{"key":"B11","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1159\/000153096","article-title":"Another abnormal trait in the serotonin metabolism path in intrauterine growth-restricted infants","volume":"95","author":"Hernandez-Rodriguez","year":"2009","journal-title":"Neonatology."},{"key":"B12","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/0028-2243(93)90025-8","article-title":"Systemic and uterine vascular response to serotonin in third trimester pregnant ewes","volume":"51","author":"Lang","year":"1993","journal-title":"Eur J Obstet Gynecol Reprod Biol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/0002-9378(67)90328-6","article-title":"Mechanism of inhibitory action of 5-hydroxytryptamine on placental function","volume":"99","author":"Honey","year":"1967","journal-title":"Am J Obstet Gynecol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1111\/j.1440-1681.2008.04975.x","article-title":"Sheep models of intrauterine growth restriction: fetal adaptations and consequences","volume":"35","author":"Morrison","year":"2008","journal-title":"Clin Exp Pharmacol Physiol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1038\/s41372-020-0598-0","article-title":"Maternal use of selective serotonin reuptake inhibitors (SSRI) during pregnancy-neonatal outcomes in correlation with placental histopathology","volume":"40","author":"Levy","year":"2020","journal-title":"J Perinatol."},{"key":"B16","first-page":"30","article-title":"Placental pathology in intrauterine growth retardation","volume":"36","author":"Park","year":"2002","journal-title":"Korian J Pathol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.jgyn.2013.09.021","article-title":"Placental features in intrauterine growth retardation","volume":"42","author":"Marcorelles","year":"2013","journal-title":"Journal De Gynecologie Obstetrique Et Biologie De La Reproduction."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e20160181","DOI":"10.1542\/peds.2016-0181","article-title":"Neonatal morbidity after maternal use of antidepressant drugs during pregnancy","volume":"138","author":"Norby","year":"2016","journal-title":"Pediatrics"},{"key":"B19","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1093\/biolre\/ioz204","article-title":"Placental serotonin signaling, pregnancy outcomes, and regulation of fetal brain development","volume":"102","author":"Rosenfeld","year":"2020","journal-title":"Biol Reprod."},{"key":"B20","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/nature09972","article-title":"A transient placental source of serotonin for the fetal forebrain","volume":"472","author":"Bonnin","year":"2011","journal-title":"Nature."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.2174\/1381612043383872","article-title":"Cardiovascular side effects of new antidepressants and antipsychotics: new drugs, old concerns?","volume":"10","author":"Pacher","year":"2004","journal-title":"Curr Pharm Design."},{"key":"B22","doi-asserted-by":"publisher","first-page":"417","DOI":"10.22038\/IJBMS.2018.27203.6650","article-title":"Effect of maternal fluoxetine exposure on lung, heart, and kidney development in rat neonates","volume":"21","author":"Ghavamabadi","year":"2018","journal-title":"Iran J Basic Med Sci."},{"key":"B23","volume-title":"Nutrient Requirements for Ruminants: Sheep, Goats, Cervids and New World Camelids","year":"2007"},{"key":"B24","doi-asserted-by":"publisher","first-page":"106043","DOI":"10.1016\/j.smallrumres.2019.106043","article-title":"Morphometric measurements of the umbilical cord and placentomes and Doppler parameters of the umbilical artery through ultrasonographic analysis in pregnant sheep","volume":"184","author":"Stankiewicz","year":"2020","journal-title":"Small Ruminant Res"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e14798","DOI":"10.14814\/phy2.14798","article-title":"Elevated serotonin coordinates mammary metabolism in dairy cows","volume":"9","author":"Connelly","year":"2021","journal-title":"Physiol Rep."},{"key":"B26","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1203\/00006450-200204000-00007","article-title":"Effect of maternal fluoxetine administration on uterine blood flow, fetal blood gas status, and growth","volume":"51","author":"Morrison","year":"2002","journal-title":"Pediatr Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0006-8993(89)90687-2","article-title":"Newborn humans and rats malnourished in utero: free plasmal-tryptophan, neutral amino acids and brain serotonin synthesis","volume":"488","author":"Hernandez","year":"1989","journal-title":"Brain Res."},{"key":"B28","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1161\/HYPERTENSIONAHA.107.094540","article-title":"Pregnant rats treated with a serotonin precursor have reduced fetal weight and lower plasma volume and kallikrein levels","volume":"50","author":"Salas","year":"2007","journal-title":"Hypertension."},{"key":"B29","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1002\/ddr.430080121","article-title":"Protective activity of ketanserin against serotonin-induced embryotoxicity and teratogenicity in rats","volume":"8","author":"Van Cauteren","year":"1986","journal-title":"Drug Dev Res."},{"key":"B30","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.ajog.2010.05.008","article-title":"Impact of antenatal selective serotonin reuptake inhibitor exposure on pregnancy outcomes in mice","volume":"203","author":"Bauer","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"63","DOI":"10.21608\/ejhm.2002.18857","article-title":"Fluoxetine Hcl induced intrauterine foetal growth retardation and skeletal malformation in pregnant mice","volume":"6","author":"Ali","year":"2002","journal-title":"Egypt J Hospital Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3390\/toxics10010011","article-title":"Effect of low and high doses of two selective serotonin reuptake inhibitors on pregnancy outcomes and neonatal mortality","volume":"10","author":"Domingues","year":"2022","journal-title":"Toxics."},{"key":"B33","doi-asserted-by":"publisher","first-page":"3520","DOI":"10.1002\/jcp.25812","article-title":"Serotonin transporter protects the placental cells against apoptosis in caspase 3-independent pathway","volume":"232","author":"Hadden","year":"2017","journal-title":"J Cell Physiol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"626","DOI":"10.3389\/fmed.2022.848581","article-title":"Pregnancy complications and neonatal mortality in a serotonin transporter null mouse model: insight into the use of selective serotonin reuptake inhibitor during pregnancy","volume":"2022","author":"Domingues","year":"2022","journal-title":"Front Med"},{"key":"B35","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1677\/joe.0.0250553","article-title":"Mechanism of lethal action of 5-hydroxytryptamine on the foetus","volume":"25","author":"Robson","year":"1963","journal-title":"J Endocrinol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"e0154628","DOI":"10.1371\/journal.pone.0154628","article-title":"Maternal use of selective serotonin reuptake inhibitors and lengthening of the umbilical cord: indirect evidence of increased foetal activity-a retrospective cohort study","volume":"11","author":"Kivisto","year":"2016","journal-title":"PLoS ONE"},{"key":"B37","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1038\/nature00819","article-title":"Placental-specific IGF-II is a major modulator of placental and fetal growth","volume":"417","author":"Constancia","year":"2002","journal-title":"Nature."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.3389\/fphys.2018.01884","article-title":"The possible role of placental morphometry in the detection of fetal growth restriction","volume":"9","author":"Salavati","year":"2019","journal-title":"Front Physiol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1055\/s-0035-1570379","article-title":"Role of the placenta in preterm birth: a review","volume":"33","author":"Morgan","year":"2016","journal-title":"Am J Perinatol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.smallrumres.2012.05.013","article-title":"A clinical and hemogasometric survey of neonatal lambs","volume":"108","author":"Vannucchi","year":"2012","journal-title":"Small Ruminant Res."},{"key":"B41","doi-asserted-by":"publisher","first-page":"106340","DOI":"10.1016\/j.smallrumres.2021.106340","article-title":"Daily dynamic changes of blood acid-base status and vital parameters in lambs and goat kids over the first seven days after birth","volume":"197","author":"Arfuso","year":"2021","journal-title":"Small Ruminant Res"},{"key":"B42","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s12916-017-0928-z","article-title":"Reduced growth velocity across the third trimester is associated with placental insufficiency in fetuses born at a normal birthweight: a prospective cohort study","volume":"15","author":"MacDonald","year":"2017","journal-title":"Bmc Medicine"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2019-2493","article-title":"Prenatal antidepressant use and risk of adverse neonatal outcomes","author":"Bandoli","year":"2020","journal-title":"Pediatrics"},{"key":"B44","doi-asserted-by":"publisher","first-page":"bcr2015209418","DOI":"10.1136\/bcr-2015-209418","article-title":"Serotonin syndrome in a breast-fed neonate","volume":"2015","author":"Morris","year":"2015","journal-title":"Case Rep"},{"key":"B45","doi-asserted-by":"publisher","first-page":"e20192250","DOI":"10.1542\/peds.2019-2250","article-title":"Why the maternal medication list matters: neonatal toxicity from combined serotonergic exposures","volume":"147","author":"Brajcich","year":"2021","journal-title":"Pediatrics"},{"key":"B46","doi-asserted-by":"publisher","first-page":"F147","DOI":"10.1136\/fn.85.2.F145g","article-title":"Neonatal paroxetine withdrawal syndrome or actually serotonin syndrome?","volume":"85","author":"Isbister","year":"2001","journal-title":"Arch Dis Child Fetal Neonatal Ed."},{"key":"B47","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1177\/0269881105056554","article-title":"Neonatal symptoms following maternal paroxetine treatment: Serotonin toxicity or paroxetine discontinuation syndrome?","volume":"19","author":"Haddad","year":"2005","journal-title":"J Psychopharmacol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"362","DOI":"10.3109\/15513815.2013.768743","article-title":"Neonatal toxicity following maternal citalopram treatment","volume":"32","author":"Eleftheriou","year":"2013","journal-title":"Fetal Pediatr Pathol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1023\/A:1006934807375","article-title":"Metabolism and pharmacokinetics of selective serotonin reuptake inhibitors","volume":"19","author":"DeVane","year":"1999","journal-title":"Cell Mol Neurobiol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1001\/archpsyc.60.7.720","article-title":"Effects of exposure to selective serotonin reuptake inhibitors during pregnancy on serotonergic symptoms in newborns and cord blood monoamine and prolactin concentrations","volume":"60","author":"Laine","year":"2003","journal-title":"Arch Gen Psychiatry."},{"key":"B51","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1124\/pr.111.004697","article-title":"Serotonin and blood pressure regulation","volume":"64","author":"Watts","year":"2012","journal-title":"Pharmacol Rev."},{"key":"B52","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1089\/jwh.2017.6642","article-title":"Prenatal selective serotonin reuptake inhibitor use and associated risk for gestational hypertension and preeclampsia: a meta-analysis of cohort studies","volume":"27","author":"Guan","year":"2018","journal-title":"J Womens Health."},{"key":"B53","doi-asserted-by":"publisher","first-page":"E540","DOI":"10.1503\/cmaj.202604","article-title":"The impact of COVID-19 on pregnancy outcomes: a systematic review and meta-analysis","volume":"193","author":"Wei","year":"2021","journal-title":"Cmaj."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/erm.2021.19","article-title":"Female fertility under impact of COVID-19 pandemic: a narrative review","volume":"23","author":"Wang","year":"2021","journal-title":"Exp Rev Molecu Med"},{"key":"B55","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1001\/archinte.164.21.2367","article-title":"Association of risk of abnormal bleeding with degree of serotonin reuptake inhibition by antidepressants","volume":"164","author":"Meijer","year":"2004","journal-title":"Arch Intern Med."},{"key":"B56","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1097\/AOG.0000000000001200","article-title":"Postpartum hemorrhage and use of serotonin reuptake inhibitor antidepressants in pregnancy","volume":"127","author":"Hanley","year":"2016","journal-title":"Obstet Gynecol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41576-019-0169-4","article-title":"Mechanisms of early placental development in mouse and humans","volume":"21","author":"Hemberger","year":"2020","journal-title":"Nat Rev Genet."},{"key":"B58","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1093\/af\/vfz018","article-title":"Real supermodels wear wool: summarizing the impact of the pregnant sheep as an animal model for adaptive fetal programming","volume":"9","author":"Beede","year":"2019","journal-title":"Anim Front."},{"key":"B59","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.placenta.2015.03.003","article-title":"Animal models of fetal growth restriction: Considerations for translational medicine","volume":"36","author":"Swanson","year":"2015","journal-title":"Placenta."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.955560\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T04:46:03Z","timestamp":1659588363000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.955560\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,4]]},"references-count":59,"alternative-id":["10.3389\/fmed.2022.955560"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.955560","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,4]]},"article-number":"955560"}}